Sinopharm (01099): Non-executive director Zhao Bingxiang has been appointed as the chairman of the Board Nomination Committee.

SINOPHARM (01099) announced that Mr. Zhao Bingxiang, a non-executive director, has been appointed as the Chairman of the Nomination Committee, Chairman of the Board Strategic and Investment Committee, and a member of the Board Legal Compliance and Environmental, Social, and Governance Committee. Mr. Lian Wanyong, an executive director, has been appointed as a member of the Board Strategic and Investment Committee and the Board Legal Compliance and Environmental, Social, and Governance Committee, all effective on September 14, 2024.